Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with CHRS: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
CHRS
Coherus Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
CHRS
Coherus Oncology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
AMGN
Amgen Inc
Change
461.49
▼
−3.55%
· post 460.22
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
CHRS
Coherus Oncology, Inc.
Change
0.86
▲
+0.75%
· post 0.75
Closed
Nov 5 '26
Mkt cap
$131.4M
Revenue
$14M
Q2 FY26
Revenue
$42M
FY25
vs
Compare
Closed
Nov 5 '26
AMGN
Amgen Inc
vs
CHRS
Coherus Oncology, Inc.
461.49
▼
−3.55%
post 460.22
Price
0.86
▲
+0.75%
post 0.75
$249.0B
Mkt cap
$131.4M
Q3 FY26
$10.4B
Revenue
$14M
Q2 FY26
FY25
$36.8B
Revenue
$42M
FY25
Change
Change
AMGN
461.49
▼
−3.55%
vs
CHRS
0.86
▲
+0.75%
Closed
Nov 5 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
CHRS: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only CHRS
7
GSK
GlaxoSmithKline
supplier
INO
Inovio Pharmaceuticals
customer
—
Junshi Biosciences
unlisted
supplier
—
Janssen Research & Development
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
3 more · CHRS chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
CHRS, dashed